A detailed history of Voisard Asset Management Group, Inc. transactions in Abb Vie Inc. stock. As of the latest transaction made, Voisard Asset Management Group, Inc. holds 536 shares of ABBV stock, worth $94,904. This represents 0.04% of its overall portfolio holdings.

Number of Shares
536
Previous 472 13.56%
Holding current value
$94,904
Previous $81 Million 30.75%
% of portfolio
0.04%
Previous 0.04%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 25, 2024

BUY
$163.84 - $199.33 $10,485 - $12,757
64 Added 13.56%
536 $106 Million
Q2 2024

Jul 15, 2024

SELL
$154.79 - $180.76 $8,668 - $10,122
-56 Reduced 10.61%
472 $81 Million
Q1 2024

Apr 16, 2024

SELL
$159.82 - $182.1 $5,114 - $5,827
-32 Reduced 5.71%
528 $96.1 Million
Q4 2023

Feb 20, 2024

BUY
$137.6 - $154.97 $77,056 - $86,783
560 New
560 $86.8 Million

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $313B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track Voisard Asset Management Group, Inc. Portfolio

Follow Voisard Asset Management Group, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Voisard Asset Management Group, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Voisard Asset Management Group, Inc. with notifications on news.